Comparison

Pulchinenoside C European Partner

Item no. TMO-T3910-500mg
Manufacturer TargetMol
CASRN 129741-57-7
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 20 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Formula C59H96O26
Smiles [H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O[C@]4([H])OC[C@H](O)[C@H](O)[C@H]4O[C@]4([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@](C)(CO)[C@]3([H])CC[C@@]12C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)C(C)=C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Anemoside B4,Chinensioside A,Pulchinenoside B4,Pulsatilla saponin B4
Shipping Condition Cool pack
Available
Manufacturer - Targets
IL Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
1221.38
Description
Pulchinenoside C (Anemoside B4) is an abundant triterpenoid saponin isolated from P. chinensis, exhibiting significant anti-inflammatory and antioxidant properties.
Pathways
Immunology/Inflammation
Bioactivity
Anemoside B4 inhibits the secretion of IL-10.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close